Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 expr

Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 expr

Item
http://www.wikidata.org/entity/Q34408283
Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot studyA new surgical technique of pancreaticoduodenectomy with splenic artery resection for ductal adenocarcinoma of the pancreatic head and/or body invading splenic artery: impact of the balance between surgical radicality and QOL to avoid total pancreatSignificance of Simultaneous Splenic Artery Resection in Left-Sided Portal Hypertension After Pancreaticoduodenectomy with Combined Portal Vein ResectionHuman Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma UndergoiCellular and molecular aspects of pancreatic cancer.Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients.How to treat borderline resectable pancreatic cancer: current challenges and future directions.Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer.R0 Resection for Locally Advanced Pancreatic Cancer with Low-dose Gemcitabine with Wide Irradiation Area as Neoadjuvant Chemoradiotherapy
P2860

Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 expr

Item
http://www.wikidata.org/entity/Q34408283
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Gemcitabine-based chemoradioth ...... nucleoside transporter 1 expr
@ast
Gemcitabine-based chemoradioth ...... nucleoside transporter 1 expr
@en
Gemcitabine-based chemoradioth ...... nucleoside transporter 1 expr
@nl
type
label
Gemcitabine-based chemoradioth ...... nucleoside transporter 1 expr
@ast
Gemcitabine-based chemoradioth ...... nucleoside transporter 1 expr
@en
Gemcitabine-based chemoradioth ...... nucleoside transporter 1 expr
@nl
prefLabel
Gemcitabine-based chemoradioth ...... nucleoside transporter 1 expr
@ast
Gemcitabine-based chemoradioth ...... nucleoside transporter 1 expr
@en
Gemcitabine-based chemoradioth ...... nucleoside transporter 1 expr
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Gemcitabine-based chemoradioth ...... nucleoside transporter 1 expr
@en
P2093
P2860
P304
P31
P356
10.1097/MPA.0000000000000059
P433
P478
P577
P698
P921
P932